Multiple law-firm announcements report that PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is facing a securities class action alleging violations of U.S. securities laws. The filings, as described by the outlets, relate to purchasers of PRCT common stock during a specified class period from February 28, 2024 through February 25, 2026. The complaints generally focus on whether the company’s regulatory filings and other public risk disclosures adequately warned investors about risks connected to the company’s handpiece inventory and related sales performance, including allegations that discount-driven dynamics contributed to an inventory buildup and later share-price declines.
Several notices also emphasize investor participation, stating that eligible shareholders may lead the case or act as class members by contacting the respective firms. Outlets further highlight that September 22, 2026 is a key deadline for investors to take action, as stated in the announcements. The reports do not include court findings or a determination of wrongdoing, and the company is not described as admitting any allegations.
